Comparison of Dabigatran Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial
Authors
Ezekowitz MD, Nagarakanti R, Noack H, Brueckmann M, Litherland C, Jacobs M, Clemens A, Reilly PA, Connolly SJ, Yusuf S, Wallentin L
Journal
Circulation
Publication Date
2016
Impact Factor
17.047
Abstract
Additional IDs
Comparison of Dabigatran Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens